These findings suggest that elevated NT-proBNP concentrations may identify a subgroup of patients with occult cardioembolic stroke mechanism (e.g., undiagnosed AF, atrial myopathy, or subclinical systolic heart failure), who could benefit from oral anticoagulation. This evidence concerns the gene NPPB and atrial fibrillation.